Eli Lilly to invest over $1 billion in Hyderabad, expand manufacturing and quality operations
US pharmaceutical company Eli Lilly and Company will invest more than $1 billion in new contract manufacturing operations in India, with a major manufacturing and quality facility to be established in Hyderabad, reported by ANI. The multi-year investment aims to expand global access to Lilly’s medicines and strengthen its supply capabilities, marking one of the…